Cancer BiologybioRxivPreprint
Covalent Inhibition of the Human Papillomavirus Type 16 E6 Protein Restores p53 and Suppresses HPV-Driven Tumorigenesis
Anne Rietz, Lokesh Kumari Kadian, Ankeeta Koirala…·Elliot J. Androphy
The paper develops covalent inhibitors targeting HPV16 E6 protein, restoring p53 function and suppressing HPV-driven tumorigenesis in vitro and in vivo.
3 citations